Amin Sikander, Synkrato co-founder & president, examines the trends within pharma manufacturing that will incur as its processes become smarter, more data-driven and transparent.
Key insights:
- Patient safety is an Industry 4.0 technology driver, by aggregating real-time data and transfer it to a centralised data hub, monitored regularly to protect patients.
- Blockchain technology can detect product anomalies, and recalls can be done even before the counterfeit enters the supply chain, thereby protecting the brand’s reputation and patient safety.
- Industry 4.0 provides pharma with new ways to analyse previous, current, and future production conditions to predict outcomes using AI.
Conversations around the fourth industrial revolution, commonly known as “smart factory” or “Industry 4.0,” have been sweeping the globe, and manufacturing processes powered by artificial intelligence (AI), augmented reality (AR), robotics, internet of things (IoT), and the metaverse are now a reality for the pharma industry.